title: Myeloid and lymphoid dendritic cells in normal pregnancy and pre-eclampsia.
abstract: The aim of our study was to estimate the populations of peripheral blood myeloid and lymphoid dendritic cells (CD1c+, BDCA-2+) and the CD1c+ : BDCA-2+ ratio in normal pregnant women and in patients with pre-eclampsia. Fifteen women in the first, second and third trimesters of normal pregnancy, and 25 patients with pre-eclampsia were included in the study. The dendritic cells were isolated from peripheral blood, stained with monoclonal antibodies against blood dendritic cell antigens (anti-CD1c, anti-BDCA-2) and estimated using the flow cytometric method. CD1c+ and BDCA-2+ dendritic cells were present in women during all trimesters of physiological pregnancy and in pre-eclamptic patients. It was observed that the numbers of dendritic cells were significantly lower in the second trimester when compared with the first and third trimesters of normal pregnancy. Furthermore, in the second trimester, CD1c+ : BDCA-2+ ratio was higher than in the other trimesters of physiological pregnancy. All populations of dendritic cells and CD1c+ : BDCA-2+ ratio did not differ in the first and third trimesters of normal pregnancy. The percentage of BDCA-2+ dendritic cells was significantly lower in pre-eclampsia in comparison with healthy women in the third trimester of physiological pregnancy, while CD1c+ : BDCA-2+ ratio was significantly higher in pre-eclamptic patients when compared with control groups. We concluded that dendritic cells may be involved in the immune regulation during physiological pregnancy. CD1c+ and BDCA-2+ cells can influence the Th2 phenomenon which is observed during physiological pregnancy. Furthermore, it seems possible that lower BDCA-2+ cells percentage and higher CD1c+ : BDCA-2+ ratio can be associated with increased Th1-type immunity in patients with pre-eclampsia.
authors.affiliation: Department of Obstetrics and Perinatology, University School of Medicine, Lublin, Poland. dorotak@mp.pl
authors.forename: D
authors.initials: D
authors.lastname: Darmochwal-Kolarz
authors.forename: J
authors.initials: J
authors.lastname: Rolinski
authors.forename: J
authors.initials: J
authors.lastname: Tabarkiewicz
authors.forename: B
authors.initials: B
authors.lastname: Leszczynska-Gorzelak
authors.forename: J
authors.initials: J
authors.lastname: Buczkowski
authors.forename: K
authors.initials: K
authors.lastname: Wojas
authors.forename: J
authors.initials: J
authors.lastname: Oleszczuk
mesh_terms: D018949:Antigens, CD1 / Q000032:analysis; D016022:Case-Control Studies; D003713:Dendritic Cells / Q000276:immunology*; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D016130:Immunophenotyping; D037181:Lectins, C-Type / Q000032:analysis; D018655:Lymphocyte Count; D008562:Membrane Glycoproteins; D011225:Pre-Eclampsia / Q000276:immunology*; D011247:Pregnancy; D011264:Pregnancy Trimesters; D011971:Receptors, Immunologic; D018709:Statistics, Nonparametric; D018417:Th1 Cells / Q000276:immunology
chemical_list: D018949:Antigens, CD1; C443299:CLEC4C protein, human; D037181:Lectins, C-Type; D008562:Membrane Glycoproteins; D011971:Receptors, Immunologic